Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects - Wikidata - wikimedia - TriplyDB

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

http://www.wikidata.org/entity/Q28370354

about

Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 PPARs and the cardiovascular system Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives Nuclear receptors in bone physiology and diseases Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review Fibrates, glitazones, and peroxisome proliferator-activated receptors Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta Pharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes.Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling.Therapeutic Implications of PPARgamma in Human Osteosarcoma.Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients.Biology of senescent liver peroxisomes: role in hepatocellular aging and disease A combined ligand- and structure-based virtual screening protocol identifies submicromolar PPARγ partial agonists Regulation of lipid and lipoprotein metabolism by PPAR activators.Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor ex The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.Identification of selective class II histone deacetylase inhibitors using a novel dual-parameter binding assay based on fluorescence anisotropy and lifetime.Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond.The G0/G1 switch gene 2 is a novel PPAR target gene.In vivo activation of PPAR target genes by RXR homodimers.Novel insulin sensitizers: pharmacogenomic aspects.Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities Revisiting PPARγ as a target for the treatment of metabolic disorders Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome.Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis.Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor β.Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.

P2860

Q24523697-2E9AFC05-1CCC-470A-9BA7-E5FD9D9655F0 Q24603087-77DAFD16-75D3-4ABB-9C01-43A3C27A39F8 Q24633440-CE78A20C-321B-4575-9F9B-8325ACF8FE00 Q24642728-B55DEFA2-5AFB-4916-BB53-1DDB5843706E Q24796541-989EF72C-229D-4A02-B7AD-10AA57C26D71 Q24803926-F5495003-7CF3-4134-9849-CFC9645B9853 Q26747009-6F845B57-0FCA-4EFE-B891-36153A4DDB69 Q26853017-F88FCF15-6AAD-4780-95E4-A7CAB542F9AF Q26866784-5E42A516-A296-429C-8F88-13651FB7664D Q28279732-B9B12E33-46CF-4016-ACE1-438C935B263E Q28343733-15C1D106-E18A-4069-A3CA-6379B53B2EC4 Q28361841-C3CC3D27-FFC6-4A81-8024-7954E2948454 Q28377342-FBCA7239-9331-40A8-A3DD-77F02CEB1FB1 Q28568373-13CD9B37-A3DB-4CBD-9F37-D62DC3445B26 Q28587698-B405F4DE-44E6-4636-98CD-F81D9997047E Q30977623-8F536624-AABA-453C-A01B-2D6379CCA0EF Q31537639-77ACDD83-60ED-48D0-8440-AD0E4C4BAA52 Q33674615-8D63B8AF-1EE3-4FCA-9D8E-414C6C25A064 Q33686312-0031CF37-CE44-4972-ADB4-F291E73185BA Q33742431-22E78055-A4C0-4D02-82B1-07B6B50E396C Q33772720-BCF1CD7A-C1FB-4A11-84FE-283DF7C27343 Q33896369-C60CC147-C873-4E38-ABB0-56D4A3D26585 Q33952364-1CFE5E93-124A-4A66-8328-AA81842B1B55 Q34035340-8470DE23-E5AD-4081-92F8-BE81D22D2031 Q34057844-E93A5FEB-9898-468C-B423-7450C6E2EEDA Q34405645-5680AF8F-BC11-4369-A9F8-957C8158E199 Q34441198-0F8F2FB5-E7F1-48B6-A0D2-E4BCC7A872B3 Q34569879-405A6D31-F00E-4760-A177-126A1317CD4D Q34609164-3A2D0CC2-8A89-45A6-A776-38661083CC5F Q34625038-A562778E-775F-491D-8E4F-57BBACCDCC21 Q34798213-0104BCEA-37C6-4754-AF57-21DE694F9B8C Q34808268-B83BADE0-A0B4-43A9-AC7C-836C1C6AA3AE Q35053566-A7B4FB60-2984-4BD2-A9F3-C20790DFCB75 Q35207615-C9C548DD-CE07-47CC-A19A-96E53BA3E258 Q35569436-FC23843C-2103-448E-A23F-E92A16ECA01F Q35613331-970895F2-388A-4D46-9257-D388E09EC639 Q35961671-CC1B4265-840D-4AEA-8D91-DAED399F36F9 Q36059868-15DBE8C4-A206-402B-8602-9A450A8918F0 Q36074920-872EDF02-E33C-44EC-BC80-A57CC4576DF3 Q36219006-1C4363F8-2CEC-4303-8594-8B02CFEED7B7

P2860

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

http://www.wikidata.org/entity/Q28370354

description

1999 nî lūn-bûn

@nan

1999 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մարտին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Novel peroxisome proliferator- ...... ce distinct biological effects

@ast

Novel peroxisome proliferator- ...... ce distinct biological effects

@en

Novel peroxisome proliferator- ...... ce distinct biological effects

@nl

type

label

Novel peroxisome proliferator- ...... ce distinct biological effects

@ast

Novel peroxisome proliferator- ...... ce distinct biological effects

@en

Novel peroxisome proliferator- ...... ce distinct biological effects

@nl

prefLabel

Novel peroxisome proliferator- ...... ce distinct biological effects

@ast

Novel peroxisome proliferator- ...... ce distinct biological effects

@en

Novel peroxisome proliferator- ...... ce distinct biological effects

@nl

P1433

Q28370354-08DEAD8F-DF74-4364-B377-ADBA6DE538BE

P1476

Q28370354-718F0536-DA0E-4D37-9E69-EC1836C85FB1

P2093

Q28370354-09CC54B0-EDFB-4052-A61E-906973C87E72

Q28370354-1B1D157D-EFE4-4BE0-8A45-4CAD045F5AB4

Q28370354-22406311-360B-4699-88BC-0744FFBB41DF

Q28370354-2D04D99D-4E35-407A-A406-FAEA89CE7905

Q28370354-2E95825D-1775-4796-8D2F-FC80D15FC4FC

Q28370354-38FBCF40-E4C2-44A1-8D20-17550C87F108

Q28370354-498D7FD8-DE8C-4A2D-8560-167B0928BDAE

Q28370354-60A56A19-7726-4144-B72D-00F1767A8A81

Q28370354-7A0CF071-4346-484D-BD4F-5820160228C0

Q28370354-86C0154F-E3A2-4F81-AEB5-D321E53D29DB

P2860

Q28370354-00AD93B7-2468-4196-9A1D-8A20DDD78BF3

Q28370354-0C4CFF20-2EA3-4A32-B350-0BAD040FBEEF

Q28370354-10DB3E42-CE74-453F-8B6B-C466A9926832

Q28370354-1638089D-986C-4AC4-A970-D23D08268FCF

Q28370354-1B53E24F-B232-40D4-A7F9-35B2FFB931B2

Q28370354-1F23098C-E309-423B-9E5C-0A2DB38B7629

Q28370354-2A100447-2A9E-435E-B70F-826509C07BB4

Q28370354-3AD87AC3-5D2F-471B-AB6E-5C86A1A432AF

Q28370354-431617C5-3FB9-491D-B796-5AB993905EC6

Q28370354-4476719F-DB5A-4F37-B7A1-9538FCF8C048

P304

Q28370354-42852CDD-B0E6-467B-BD6A-1C42DB9A1F4B

P31

Q28370354-1DA4D9F4-20A7-48F8-9170-9D458C9CE0F9

P3181

Q28370354-BFCD795D-01B9-4A87-ACE3-9510AD912E0A

P356

Q28370354-45C3B38E-0FFB-4F49-B8E2-0B614E147A77

P407

Q28370354-E5343AB8-1279-45D6-AD4C-AEFB87047906

P433

Q28370354-6F3B4CD9-63BD-4FB9-875C-704C732FDA18

P478

Q28370354-EC42D8C2-7654-4579-A111-9ACEDF3F8E2E

P577

Q28370354-F45CA8A3-1F03-4C93-8883-AF90974CB47F

P698

Q28370354-01A8F135-70B6-41A8-9EAA-069F10B41F6B

P3181

P356

JBC.274.10.6718

P1433

Journal of Biological Chemistry

P1476

Novel peroxisome proliferator- ...... ce distinct biological effects

@en

P2093

A Elbrecht

http://www.w3.org/2001/XMLSchema#string

B Zhang

http://www.w3.org/2001/XMLSchema#string

C A Cullinan

http://www.w3.org/2001/XMLSchema#string

C Biswas

http://www.w3.org/2001/XMLSchema#string

C Santini

http://www.w3.org/2001/XMLSchema#string

D E Moller

http://www.w3.org/2001/XMLSchema#string

G D Berger

http://www.w3.org/2001/XMLSchema#string

G Zhou

http://www.w3.org/2001/XMLSchema#string

J Berger

http://www.w3.org/2001/XMLSchema#string

J Ventre

http://www.w3.org/2001/XMLSchema#string

P2860

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

The transcriptional coactivators p300 and CBP are histone acetyltransferases

Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase

Steroid receptor coactivator-1 is a histone acetyltransferase

p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

P304

6718-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1304027

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.274.10.6718

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

274

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10037770

http://www.w3.org/2001/XMLSchema#string